SCHEMBL7514477

SCHEMBL7514477

CN(C)C(OC(=O)CP(=O)(O)O)OC(=O)CP(=O)(O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
BLM P54132 1/20 0.36
KMT2A Q03164 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ENO1 P06733 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
GRIN2D O15399 1/20 0.32
GRIN3B O60391 1/20 0.32
GRIN1 Q05586 1/20 0.32
GRIN2A Q12879 1/20 0.32
GRIN2B Q13224 1/20 0.32
GRIN2C Q14957 1/20 0.32
GRIN3A Q8TCU5 1/20 0.32
FDPS P14324 1/20 0.31
PGK1 P00558 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1327181 0.76 LMNA (0.42) MEN1LMNAHPGDTSHRBLM
SCHEMBL3283984 0.72 LAP3 (0.38) MEN1LMNAHPGDTSHRBLM
SCHEMBL7836561 0.72 MEN1 (0.37) MEN1LMNAHPGDTSHRBLM
SCHEMBL19347004 0.72 MEN1 (0.37) MEN1LMNAHPGDTSHRBLM
SCHEMBL5961220 0.71 LAP3 (0.37) MEN1LMNAHPGDTSHRBLM
Trimethylammonium SCHEMBL27626198 0.70 MEN1 (0.39) MEN1LMNAHPGDTSHRBLM
SCHEMBL3213968 0.70 MGAM (0.48) MEN1KMT2A
SCHEMBL360260 0.67
SCHEMBL831709 0.67 PRKCA (0.44) CYP2D6CYP2C9CYP2C19FDPS
SCHEMBL11517632 0.67 LPAR3 (0.41) LMNATDP1CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020107401-A1 Production of phosphonopyrazoles MONSNTO TECHNOLOGY LLC. 2002-08-08 US disclosed
EP-1149108-A1 PRODUCTION OF PHOSPHONOPYRAZOLES Monsanto Co. (US) 2001-10-31 EP disclosed
US-6297194-B1 INDUCING MALE STERILITY IN PLANTS BY TREATING PLANTS OR SEEDS WITH GAMETOCIDES MONSANTO TECHNOLOGY, LLC 2001-10-02 US disclosed
WO-2000046229-A1 PRODUCTION OF PHOSPHONOPYRAZOLES MONSANTO TECHNOLOGY LLC (US) 2000-08-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107401-A1 Production of phosphonopyrazoles PPIP5K2, PCK2, PFKFB4 MEN1 3742/4885LMNA 4742/4885HPGD 845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.